ISOPLEXIS
IsoPlexis is a life science technology company developing a single-cell detection system that identifies a wide range of patient immune responses at the single-cell level. Its platform can assess the safety and efficacy of therapeutics and monitor disease progression, enabling improved therapeutic development, and informing physician decisions. The company was founded in 2013 and is headquartered in Branford, Connecticut.
ISOPLEXIS
Social Links:
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2013-01-01
Address:
Branford, Connecticut, United States
Country:
United States
Website Url:
http://www.isoplexis.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
330.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Perceptive Advisors
Perceptive Advisors investment in Series D - IsoPlexis
Ally Bridge Group
Ally Bridge Group investment in Series D - IsoPlexis
BlackRock
BlackRock investment in Series D - IsoPlexis
BlackRock
BlackRock investment in Debt Financing - IsoPlexis
Ally Bridge Group
Ally Bridge Group investment in Debt Financing - IsoPlexis
Perceptive Advisors
Perceptive Advisors investment in Debt Financing - IsoPlexis
National Institute on Aging
National Institute on Aging investment in Grant - IsoPlexis
Spring Mountain Capital
Spring Mountain Capital investment in Series C - IsoPlexis
Northpond Ventures
Northpond Ventures investment in Series C - IsoPlexis
Connecticut Innovations
Connecticut Innovations investment in Series C - IsoPlexis
Official Site Inspections
http://www.isoplexis.com Semrush global rank: 2.03 M Semrush visits lastest month: 10.4 K
- Host name: 172.67.194.146
- IP address: 172.67.194.146
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "IsoPlexis"
IsoPlexis - Crunchbase Company Profile & Funding
IsoPlexis may be growing as it was involved in a significant acquisition by Berkeley Lights, indicating a positive valuation and interest from larger entities in the biotechnology industry. …See details»
IsoPlexis | Lab Manager
Apr 29, 2021 IsoPlexis is revolutionizing single-cell proteomics with its advanced platforms that provide insights into the functional biology of cells. Their technology is pivotal in advancing …See details»
Isoplexis Company Profile | Management and Employees List
IsoPlexis is dedicated to accelerating the fight against cancer and a range of our toughest diseases by producing the worlds most precise, award-winning detection systems. By …See details»
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional ...
Dec 21, 2022 Complementary Technologies, Customer Bases, and Commercial Channels to Strengthen Leadership in High-Growth, Single-Cell Biology Significant Cost Synergies to …See details»
IsoPlexis - Funding, Financials, Valuation & Investors - Crunchbase
IsoPlexis is registered under the ticker NASDAQ:ISO . Their stock opened with $15.00 in its Oct 8, 2021 IPO. IsoPlexis is funded by 14 investors. Perceptive Advisors and Ally Bridge Group are …See details»
IsoPlexis Company Profile 2024: Valuation, Investors
IsoPlexis General Information Description. Developer of a single-cell detection system designed to identify patient immune responses at the single-cell level. The company specializes in developing cell-based proteomic systems and …See details»
IsoPlexis Corporation - AnnualReports.com
IsoPlexis is empowering labs to leverage the cells and proteome changing the course of human health. By leading the discovery and identification of how multi-functional immune cells communicate and respond, IsoPlexis assists …See details»
IsoPlexis - Contacts, Employees, Board Members, Advisors & Alumni
Organization. IsoPlexis . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... IsoPlexis has 6 current employee profiles, including Co-Founder & SAB …See details»
IsoPlexis Company Profile - Office Locations, Competitors ... - Craft
IsoPlexis is a company that develops a diagnostic platform for immunology research and therapeutic development. It offers diagnosis kits, instrumentation, and software and focuses on …See details»
IsoPlexis CEO and Key Executive Team | Craft.co
IsoPlexis's Co-Founder, CEO, Director is Sean MacKay. Other executives include Jing Zhou, CSO; John G. Conley, Chairman of Board and 23 others. See the full leadership team at Craft.See details»
Annual Reports - IsoPlexis
The Investor Relations website contains information about IsoPlexis's business for stockholders, potential investors, and financial analysts.See details»
IsoPlexis IPO - Linqto
IsoPlexis, founded in 2013 and headquartered in Branford, Connecticut, is a company that develops a diagnostic platform to accelerate immunology research and therapeutic …See details»
IsoPlexis | CipherBio
Explore IsoPlexis's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
IsoPlexis Strengthens International Reach and Leadership with First ...
Feb 2, 2022 IsoPlexis Strengthens International Reach and Leadership with First APAC Office and Jason Ou as President/General Manager, APAC Region. ... has 5000 square feet of office …See details»
IsoPlexis - Crunchbase
Companies like IsoPlexis include Tango Therapeutics, Passage Bio, and Excision BioTherapeutics. Passage Bio Philadelphia , Pennsylvania , United States 85 Contacts 101 …See details»
Duomic: IsoPlexis Introduces Integrated Single-Cell Functional …
IsoPlexis believes that the combined data Duomic delivers will be able to provide insights into the link between functional heterogeneity and the gene drivers of protein activity in individual cells. …See details»
IsoPlexis (ISO) Stock Price, News & Analysis - MarketBeat
Nov 24, 2024 IsoPlexis had a negative trailing twelve-month return on equity of 127.86% and a negative net margin of 632.41%. When did IsoPlexis IPO? IsoPlexis (ISO) raised $125 million …See details»
Bruker Cellular Analysis | Bruker
Bruker Cellular Analysis is uniquely enabling the exploration of the phenome and mastery of single cells for all labs & scientists through a simple and accessible workflow.See details»
IsoPlexis - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 24, 2024 IsoPlexis uses 30 technology products and services including HTML5, Lightbox, and Microsoft Outlook, according to G2 Stack. IsoPlexis is actively using 25 technologies for …See details»
IsoPlexis’ Immune Monitoring Helps Identify Early Factors of Long …
Feb 10, 2022 Single-cell functional proteomics identifies biological factors and immune cell types that drive Long COVID in convalescent COVID-19 patientsBRANFORD, Conn., Feb. 10, 2022 …See details»